← Human Trials & Peer-Reviewed Studies
Vitamin D response of older people in residential aged care to sunlight-derived ultraviolet radiation.
Plain-language guide to PMID 25311734 (2014): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 248 participants.
Key Facts
- PMID
- 25311734
- Journal
- Archives of osteoporosis
- Year
- 2014
- Study type
- Randomized Controlled Trial
- Authors
- Durvasula S et al. (13 authors)
- DOI
- 10.1007/s11657-014-0197-9
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
The aim of this study was to determine the vitamin D response to sunlight ultraviolet radiation in older people.
The purpose of this study is to measure the ultraviolet radiation (UVR) exposure of those in residential aged care in an earlier trial of sunlight exposure and to determine its effect on their vitamin D response.
Why It Was Studied
Natural sun exposure is not a practical intervention for vitamin D deficiency in this population.
Who Took Part
According to the abstract, 248 participants were involved.
The age groups tagged for this paper are people over 80, both men and women.
Attendance data, demographic, clinical and biochemical variables for 248 participants were used for a secondary analysis of a previous cluster randomized trial of sunlight exposure and falls.
How the Study Was Run
In design terms this was a randomized study.
The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
What Was Measured
PubMed files the paper under topics including Calcium, Radiometry, Sunlight, Vitamin D and Vitamin D Deficiency.
What This Means in Plain Language
The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 248 participants.
Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2014 (Archives of osteoporosis), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.